According to admission glycemia and DM diagnostic criteria , the patients were then divided in 460 non-T2DM vs 188 T2DM patients.
Finally, the T2DM patients were under chronic SGLT2-I therapy, so they were not randomized to the SGLT2-I therapy.
The diagnosis of stable CHD was made according to international recommendations.